b.fab specializes in CO2-based biofabrication, focusing on utilizing carbon dioxide for the creation of biopolymers and other sustainability-focused products.

b.fab

IPhone / Mobile Compatible

Viewport Meta

SSL by Default

Apple Mobile Web Clips Icon

Google Font API

Content Delivery Network

WordPress

Font Awesome

IPv6

Frank Kensy

Managing Director & Co-Founder

Sustainability Seed Stage Companies With Fewer Than 10 Employees

European Union (EU) Biotechnology Companies

Sustainability Seed Stage Companies With Fewer Than 100 Employees

Europe, Middle East, and Africa (EMEA) Biotechnology Companies (Top 10K)

B.fab specializes in the conversion of CO2 and hydrogen from renewable energy into biotechnological value chains.

It utilizes formate as its central mediator to bind and store CO2 and H2 (made from water) in liquid form. The company's bioprocesses start with the feedstock formate and it uses synthetic biology to design specific pathways and to convert formate into value-added chemicals. The platform is built on anaerobic and aerobic microbial production hosts to provide flexibility in the process design and adaptation to specific product requirements. B.fab GmbH applies laboratory automation, high-throughput experimentation, and advanced bioprocess development in an agile environment to develop new bioprocesses efficiently and in a minimal time frame. 

It was founded in 2018 in Dortmund, Nordrhein-Westfalen.

b.value AG

Seed Round - b.fab

Grant - b.fab

Köln

Nordrhein-Westfalen

Germany

Europe

Licence for using synthetic pathways in microbial hosts that utilize formic acid as the sole carbon source.

Production of formic acid from CO2, water, and renewable electricity through electrochemical processes.

Development of bioprocesses using formic acid as a substrate with formatotrophic strains to produce various chemicals, proteins, amino acids, and biopolymers.

Design and engineering of synthetic pathways to direct formic acid into desired bioproducts.

Application of miniaturization and laboratory automation techniques to enhance bioprocess development.

Utilization of high-throughput experimentation methods to accelerate bioprocess development.

Romania

Tunisia

Africa

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 29, 2024 5:30 AM	047328ef
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 29, 2024 5:30 AM	d9ad41e6
crunchbase trigger	general	Dec 4, 2024 8:54 AM	06203ab6
crunchbase profile	general	Dec 4, 2024 4:38 PM	ac919a2e
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 4:54 PM	719aa461
peers	general	Oct 29, 2024 5:30 AM	4ab1be76
news basic	general	Oct 29, 2024 5:30 AM	d83f726c
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BFAB

BIO:BFAB

b.fab